<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The patient was a 77-year-old woman with multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> of sigmoid <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>She underwent low anterior resection for sigmoid <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>After surgery, she selected oral administration of UFT and LV for <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and multiple <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>After two courses, the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> had markedly diminished </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-two months later, <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> had disappeared on computer tomography </plain></SENT>
<SENT sid="5" pm="."><plain>This therapy was continued for five years, and recurrences are no longer shown </plain></SENT>
<SENT sid="6" pm="."><plain>Severe adverse effects were not observed </plain></SENT>
<SENT sid="7" pm="."><plain>Oral anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs can serve as effective therapy for advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> of old patients </plain></SENT>
</text></document>